Salahuddin, Nurul Husna;Herlitzius, Emilia;Schütz, Alexandra;Siafis, Spyridon;Priller, Josef;Leucht, Stefan;Bighelli, Irene
Psychological and Psychosocial Interventions for People With Schizophrenia and Co-Occurring Substance Use Disorders: A Systematic Review and Meta-Analysis.
JAMA Psychiatry
2026
83
4
353-362

Blujdea, Elena-Raluca;van Bokhoven, Pieter;Martino-Adami, Pamela V;Marshe, Victoria S;Vromen, Ellen M;Hok-A-Hin, Yanaika S;Boiten, Walter A;Irwin, David J;Chen-Plotkin, Alice S;Lemstra, Afina W;Pijnenburg, Yolande;van der Flier, Wiesje M;Peters, Oliver;Hellmann-Regen, Julian;Priller, Josef;Schneider, Anja;Wiltfang, Jens;Jessen, Frank;Düzel, Emrah;Buerger, Katharina;Perneczky, Robert;Teipel, Stefan;Laske, Christoph;Brosseron, Frederic;Del Campo, Marta;Wijdeven, Ruud;Visser, Pieter-Jelle;Tijms, Betty M;De Jager, Philip L;Ramirez, Alfredo;Teunissen, Charlotte E;Vermunt, Lisa
Microglia protein profiles in CSF across Alzheimer's disease clinical stages.
Nat Aging
2026
6
3
520-533

Furukawa, Yuki;Lin, Xiao;Rodolico, Alessandro;Tian, Jing;Wu, Hui;Schneider-Thoma, Johannes;Priller, Josef;Davis, John M;Leucht, Stefan;Siafis, Spyridon
Antipsychotic dose and efficacy for acute schizophrenia spectrum disorders: an updated systematic review and dose-response meta-analysis.
EClinicalMedicine
2026
94

Kataoka, Yuki;Takayama, Tomohiro;Yoshimura, Keisuke;So, Ryuhei;Tsujimoto, Yasushi;Yamagishi, Yosuke;Takagi, Shiro;Furukawa, Yuki;Sakata, Masatsugu;Bašić, Đorđe;Cipriani, Andrea;Cuijpers, Pim;Karyotaki, Eirini;Harrer, Mathias;Leucht, Stefan;Homiar, Ava;Ostinelli, Edoardo G;Miguel, Clara;Rodolico, Alessandro;Furukawa, Toshi A
Automating the data extraction process for systematic reviews using GPT-4o and o3.
Res Synth Methods
2026
17
1
42-62

Burkhardt, Gerrit;Goerigk, Stephan;Bulubas, Lucia;Dechantsreiter, Esther;Keeser, Daniel;Vogelmann, Ulrike;von Wartensleben, Katharina;Wolf, Johannes;Plewnia, Christian;Fallgatter, Andreas;Langguth, Berthold;Normann, Claus;Frase, Lukas;Zwanzger, Peter;Kammer, Thomas;Schönfeldt-Lecuona, Carlos;Kamp, Daniel;Bajbouj, Malek;Koutsouleris, Nikolaos;Brunoni, Andre R;Padberg, Frank
Cross-trial prediction of treatment response to transcranial direct current stimulation in patients with major depressive disorder.
Prog Neuropsychopharmacol Biol Psychiatry
2026
144

Chen, Miaoxi;Björklund, Jonas;Chang, Kai-Yen;Burkhardt, Gerrit;Bulubas, Lucia;Weller, Simone;Hagenah, Kristin;Kesser, Daniel;Brunoni, Andre R;Padberg, Frank;Vogelmann, Ulrike
High dosage accelerated intermittent theta burst stimulation without precision targeting and dosing in depression: an open-label pilot study.
Eur Arch Psychiatry Clin Neurosci
2026
276
2
475-484

Hartung, Theresa;Freyer, Dorette;Zemella, Anne;Radbruch, Helena;Weiner, January;El-Din, Jasmin Jamal;Meisel, Andreas;Priller, Josef
Non-hematopoietic erythropoietin splice variant is produced in the diseased human brain and confers neuroprotection.
Front Cell Neurosci
2026
19

Ayyildiz, Sevilay;Neubauer, Antonia;Thalhammer, Melissa;Li, Hongwei Bran;Wendt, Jil;Menegaux, Aurore;Hippen, Rebecca;Schmitz-Koep, Benita;Schinz, David;Zimmer, Claus;Ayyildiz, Behcet;Ors, Abdullah;Bamac, Belgin;Hedderich, Dennis M;Sorg, Christian
Lifespan trajectory of claustrum volume in humans - effect of age, hemisphere, and sex, and association with cognitive performance.
Neuroimage
2026
325

Zhao, Guorui;Sun, Yaoyao;Zhang, Yuyanan;Lu, Tianlan;Lu, Zhe;Kang, Zhewei;Schneider-Thoma, Johannes;Xie, Wuxiang;Yang, Yang;Guo, Jing;Zhu, Yunqing;Yuan, Rui;Sun, Junyuan;Feng, Xiaoyang;Liao, Yundan;Chen, Dongxue;Li, Lingjiang;Li, Tao;Yang, Fude;Wang, Chuanyue;Zhang, Dai;Yan, Hao;Leucht, Stefan;Yue, Weihua
Efficacy and Tolerability of Seven Antipsychotic Drugs in Acutely Ill Patients With Schizophrenia: A Randomized, Multicenter, Assessor-Blinded Trial.
Am J Psychiatry
2026
183
2
112-123

Mortazavi, Matin;Aminifarsani, Zahra;Rossum, Inge Winter-van;Kahn, René S;Fleischhacker, W Wolfgang;Davidson, Michael;Weiser, Mark;Siskind, Dan;Leucht, Stefan;Hasan, Alkomiet;Wagner, Elias
Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial.
CNS Drugs
2026
40
1
99-109